Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.

R R Ghose, H P Upadhyay

    Postgraduate Medical Journal
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinico-pathological Profile of Kidney Biopsy Patients in a Tertiary Hospital of Central Nepal.

    Kathmandu University medical journal (KUMJ)·2021
    Same author

    Clinicodemographic Profile and Outcome of Maintenance Hemodialysis Patients in a Tertiary Hospital of Central Nepal, Chitwan.

    Kathmandu University medical journal (KUMJ)·2021
    Same author

    Acute management of severe hypertension with oral labetalol.

    British journal of clinical pharmacology·2015
    Same author

    Curable malabsorption in a 67-year-old man.

    The New Zealand medical journal·1999
    Same author

    Truffles or earthballs?

    The New Zealand medical journal·1999
    Same author

    Commotio cordis and atrial fibrillation.

    The New Zealand medical journal·1998

    Thyroid hormone replacement therapy with thyroxine in hypothyroidism can cause initial thyrotropin increases, not just decreases. This paradoxical rise, especially in less severe cases, complicates using thyrotropin to gauge treatment effectiveness.

    Area of Science:

    • Endocrinology
    • Thyroidology

    Background:

    • Primary hypothyroidism requires thyroid hormone replacement therapy.
    • Monitoring treatment efficacy often relies on serum thyrotropin levels.

    Purpose of the Study:

    • To investigate the dynamic changes in serum thyrotropin (TSH) and thyroxine (T4) concentrations during incremental oral thyroxine therapy in patients with primary hypothyroidism.
    • To explore the factors influencing TSH response and its utility as an index of euthyroidism.

    Main Methods:

    • Prospective study involving six patients with primary hypothyroidism.
    • Incremental oral thyroxine regimen administered consecutively.
    • Serial measurements of serum thyrotropin and thyroxine concentrations.

    Main Results:

    Related Experiment Videos

    • Serum thyrotropin levels generally fell over several months, with a concurrent slow rise in serum thyroxine.
    • A transient rise in thyrotropin was observed in some patients during the initial 3 months of treatment, not associated with adverse physiological effects.
    • This paradoxical thyrotropin augmentation was more common in patients with less severe initial thyroid deficiency.

    Conclusions:

    • Thyroxine therapy can elicit complex TSH responses, including paradoxical augmentation, which may reflect competing actions of the hormone.
    • The variability in TSH response, particularly the transient rise, challenges its reliability as a sole index of euthyroidism in all patients.
    • Further research is needed to understand the mechanisms and clinical implications of TSH augmentation during thyroid hormone replacement.